EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cutaneous α-Synuclein Pathology as a Differential Marker: A Histological and Statistical Comparison across Neurodegenerative Disease Groups

Dorota Šebelová, Kateřina Menšíková, Michaela Kaiserová, Lenka Satke, Zuzana Grambalová, Kateřina Čížková, Zdeněk Tauber, Kateřina Klíčová, Dominik Hraboš, Sarah E V Cook, Jana Zapletalová, Petr Kaňovský

Journal of Molecular Neuroscience · 2026

DOI: 10.1007/s12031-026-02486-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Neuroscience, 2026. Verfasst von Dorota Šebelová und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, 77900, Czech Republic. dorota.sebelova@upol.cz. Hauptthemen laut MEDLINE: alpha-Synuclein, Skin, Neurodegenerative Diseases, Synucleinopathies. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Palacky University Olomouc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is an urgent need for early and accurate biomarkers of neurodegenerative disorders. Due to the high innervation and accessibility of the skin, a skin biopsy is a minimally invasive method of detecting phosphorylated α-synuclein (p-α-syn) and assessing intraepidermal nerve fiber density (IENFD). We analyzed biopsies taken from the back and the leg of patients with parkinsonian syndromes (Park.sy.), α-synucleinopathies, multiple system atrophies (MSA), tauopathies, and other neurological disorders, as well as from healthy controls. Double immunofluorescence was performed for p-α-syn (Ser129) and protein gene product 9.5 (PGP 9.5), alongside quantitative IENFD assessment. p-α-syn was significantly more prevalent in the patient groups than in the control group. The highest prevalence was observed in patients with parkinsonian syndromes, α-synucleinopathies and MSA. Tauopathies showed preferential paravertebral positivity. Reduction or absence of IENFD was most pronounced in tauopathies (75%), while IENFD was most commonly preserved in MSA (83.3%), indicating that disease-specific patterns of peripheral nerve involvement are exhibited. p-α-syn positivity was found to correlate with shorter disease duration, suggesting its potential as an early biomarker. Combined with olfactory testing, cutaneous markers improved diagnostic discrimination. Our findings support the use of skin biopsies as a promising clinical tool in diagnosing biomarker-based neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinSkinNeurodegenerative DiseasesSynucleinopathiesHumansMaleFemaleBiomarkersUbiquitin ThiolesteraseAgedMiddle AgedMultiple System AtrophyTauopathiesNerve Fibers

Stichwörter der Autor:innen

BiomarkersNeurodegenerative diseasesParkinson’s diseaseSkin biopsyTauopathiesΑ-synucleinopathies

Substanzen

alpha-SynucleinBiomarkersUbiquitin ThiolesteraseUCHL1 protein, human

Autor:innen und Institutionen

  • Department of Neurology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, 77900, Czech Republic. dorota.sebelova@upol.cz.
  • Department of Neurology, Olomouc University Hospital, Olomouc, 77900, Czech Republic. dorota.sebelova@upol.cz.
  • Department of Neurology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, 77900, Czech Republic.
  • Department of Neurology, Olomouc University Hospital, Olomouc, 77900, Czech Republic.
  • Olomouc Brain Bank, Department of Neurology and Department of Clinical and Molecular Pathology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
  • Department of Histology and Embryology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, 77900, Czech Republic.

Förderung

  • Palacky University Olomouc

Zitieren

APA

Šebelová, D., Menšíková, K., Kaiserová, M., Satke, L., Grambalová, Z., Čížková, K., Tauber, Z., Klíčová, K., Hraboš, D., Cook, S. E. V., Zapletalová, J., & Kaňovský, P. (2026). Cutaneous α-Synuclein Pathology as a Differential Marker: A Histological and Statistical Comparison across Neurodegenerative Disease Groups. Journal of Molecular Neuroscience. https://doi.org/10.1007/s12031-026-02486-0

Vancouver

Šebelová D, Menšíková K, Kaiserová M, Satke L, Grambalová Z, Čížková K, et al. Cutaneous α-Synuclein Pathology as a Differential Marker: A Histological and Statistical Comparison across Neurodegenerative Disease Groups. Journal of Molecular Neuroscience. 2026. doi:10.1007/s12031-026-02486-0

BibTeX
@article{ebelov2026,
  author = {Šebelová, Dorota and Menšíková, Kateřina and Kaiserová, Michaela and Satke, Lenka and Grambalová, Zuzana and Čížková, Kateřina and Tauber, Zdeněk and Klíčová, Kateřina and Hraboš, Dominik and Cook, Sarah E V and Zapletalová, Jana and Kaňovský, Petr},
  title = {Cutaneous α-Synuclein Pathology as a Differential Marker: A Histological and Statistical Comparison across Neurodegenerative Disease Groups},
  journal = {Journal of Molecular Neuroscience},
  year = {2026},
  doi = {10.1007/s12031-026-02486-0}
}
Kostenlos starten →